[1] |
Abe M, Morimoto T, Nakagawa Y, et al. Impact of transient or persistent contrast-induced nephropathy on long-term mortality after elective percutaneous coronary intervention[J]. Am J Cardiol, 2017, 120(12): 2146-53. doi: 10.1016/j.amjcard.2017.08.036
|
[2] |
Zheng X, Curtis JP, Hu S, et al. Coronary catheterization and percutaneous coronary intervention in China: 10-year results from the China PEACE-Retrospective CathPCI study[J]. JAMA Intern Med, 2016, 176(4): 512-21. doi: 10.1001/jamainternmed.2016.0166
|
[3] |
Makris K, Spanou L. Acute kidney injury: diagnostic approaches and controversies[J]. Clin Biochem Rev, 2016, 37(4): 153-75.
|
[4] |
Solomon R, Dauerman HL. Acute kidney injury[J]. Circ Cardiovasc Interv, 2017, 10(1): 69-74.
|
[5] |
Sato A, Aonuma K, Watanabe M, et al. Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: from the CINC-J study[J]. Int J Cardiol, 2017, 227(13): 424-9.
|
[6] |
Liu YH, Liu Y, Zhou YL, et al. Comparison of different risk scores for predicting contrast induced nephropathy and outcomes after primary percutaneous coronary intervention in patients with ST elevation myocardial infarction[J]. Am J Cardiol, 2016, 117(12): 1896-903. doi: 10.1016/j.amjcard.2016.03.033
|
[7] |
Samul W, Turowska A, Kwasiborski PJ, et al. Comparison of safety of radial and femoral approaches for coronary catheterization in interventional cardiology[J]. Med Sci Monit, 2015, 21(7): 1464-8.
|
[8] |
Atanda AC, Olafiranye O. Contrast-induced acute kidney injury in interventional cardiology: Emerging evidence and unifying mechanisms of protection by remote ischemic conditioning[J]. Cardiovasc Revasc Med, 2017, 18(7): 549-53. doi: 10.1016/j.carrev.2017.06.001
|
[9] |
Pancholy MS, Skelding K, Scott T, et al. Effect of access site choice on acute kidney injury after percutaneous coronary intervention[J]. Am J Cardiol, 2017, 120(12): 2141-5. doi: 10.1016/j.amjcard.2017.08.039
|
[10] |
Rear R, Bell RM, Hausenloy DJ. Contrast-induced nephropathy following angiography and cardiac interventions[J]. Heart, 2016, 102(8): 638-48. doi: 10.1136/heartjnl-2014-306962
|
[11] |
Azzalini L, Vilca LM, Lombardo F, et al. Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: comparison of five contrast media[J]. Int J Cardiol, 2018, 273(2): 69-73.
|
[12] |
Samadian F, Dalili N, Mahmoudieh L, et al. Contrast-induced Nephropathy: Essentials and concerns[J]. Iran J Kidney Dis, 2018, 12(3): 135-41.
|
[13] |
Reinstadler SJ, Kronbichler A, Reindl M, et al. Acute kidney injury is associated with microvascular myocardial damage following myocardial infarction[J]. Kidney Int, 2017, 92(3): 743-50. doi: 10.1016/j.kint.2017.02.016
|
[14] |
Hossain MA, Costanzo E, Cosentino J, et al. Contrast-induced nephropathy: pathophysiology, risk factors, and prevention[J]. Saudi J Kidney Dis Transpl, 2018, 29(1): 1-9. doi: 10.4103/1319-2442.225199
|
[15] |
He X, Yang J, Li L, et al. Atorvastatin protects against contrast-induced nephropathy via anti-apoptosis by the upregulation of Hsp27 in vivo and in vitro[J]. Mol Med Rep, 2017, 15(4): 1963-72. doi: 10.3892/mmr.2017.6251
|
[16] |
Gao Z, Han Y, Hu Y, et al. Targeting HO-1 by epigallocatechin-3-gallate reduces contrast-induced renal injury via anti-oxidative stress and anti-inflammation pathways[J]. PLoS One, 2016, 11(2): e0149032-43. doi: 10.1371/journal.pone.0149032
|
[17] |
Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization[J]. Eur Heart J, 2019, 40(2): 87-165. doi: 10.1093/eurheartj/ehy394
|
[18] |
Kronbichler A, Shin JI, Windpessl M. What is left to prevent contrast-induced acute kidney injury? No difference between low and iso-osmolar contrast media[J]. Int J Cardiol, 2018, 273(2): 94-5.
|
[19] |
Amin AP, Bach RG, Caruso ML, et al. Association of variation in contrast volume with acute kidney injury in patients undergoing percutaneous coronary intervention[J]. JAMA Cardiol, 2017, 2(9): 1007-12. doi: 10.1001/jamacardio.2017.2156
|
[20] |
Mccullough PA, Zhang J, Ronco C. Volume expansion and contrast-induced acute kidney injury[J]. Lancet (London, England), 2017, 389(176): 1277-8.
|
[21] |
Solomon R. Hydration to prevent acute kidney injury after angiography[J]. Coronary Artery Dis, 2017, 28(8): 629-31. doi: 10.1097/MCA.0000000000000515
|
[22] |
Solomon R, Lahoud R. Oral hydration[J]. Coron Artery Dis, 2018, 29(4): 283-5. doi: 10.1097/MCA.0000000000000615
|
[23] |
Zhang B, Liang L, Chen WB, et al. The efficacy of Sodium bicarbonate in preventing contrast-induced nephropathy in patients with pre-existing renal insufficiency: a meta-analysis[J]. BMJ Open, 2015, 5(3): e6989-100.
|
[24] |
Abouzeid S, Mosbah O. Evaluation of different Sodium bicarbonate regimens for the prevention of contrast medium-induced nephropathy[J]. Electron physician, 2016, 8(2): 1973-7. doi: 10.19082/1973
|
[25] |
Subramaniam RM, Suarez-Cuervo C, Wilson RF, et al. Effectiveness of prevention strategies for contrast-induced nephropathy: a systematic review and meta-analysis[J]. Ann Intern Med, 2016, 164(6): 406-16. doi: 10.7326/M15-1456
|
[26] |
Ma WQ, Zhao Y, Wang Y, et al. Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials[J]. Int Urol Nephrol, 2018, 50(6): 1085-95. doi: 10.1007/s11255-018-1814-0
|
[27] |
Katsiki N, Fonseca V, Mikhailidis DP. Contrast-induced acute kidney injury in diabetes mellitus: clinical relevance and predisposing factors. could statins be of benefit?[J] J Diab Complicat, 2018, 32(11): 982-4.
|
[28] |
Li J, Li Y, Xu B, et al. Short-term rosuvastatin therapy prevents contrast-induced acute kidney injury in female patients with diabetes and chronic kidney disease: a subgroup analysis of the TRACK-D study[J]. J Thorac Dis, 2016, 8(5): 1000-6. doi: 10.21037/jtd.2016.03.26
|